Dato 'Dr. Mohd Ibrahim A. Wahid Onkologis Médis


Konsultan - Ahli Onkologi Médis, Pangalaman:

buku pasini

Ngeunaan Dokter

Dato' Dr. Mohd Ibrahim A. Wahid mangrupikeun salah sahiji ahli onkologi luhur di Kuala Lumpur, Malaysia.

Dato' Dr Mohamed Ibrahim A. Wahid nampi gelar Bachelor of Medicine, Bachelor of Surgery (MBBCh) ti University of Wales, College of Medicine sareng gelar spesialis pascasarjana ti Royal College of Radiologists di London, Inggris (Inggris).

Saatos dilatih di Inggris, anjeunna balik deui ka Malaysia sareng nyetél Unit Kanker di Pusat Médis Universitas Malaya (UMMC) dimana anjeunna diangkat janten Kepala Onkologi Klinis sateuacan gabung di Rumah Sakit Pantai Kuala Lumpur.

In 2010, Dr Mohamed Ibrahim was appointed as the President of the Malaysian Oncological Society (MOS) and became President of the Asia Pacific Federation of Cancer Congress (APFOCC) in 2011. He was also the President of the South East Asia Radiology Oncology Group (SEAROG) from 2011 to 2013 and a Regent for South East Asia’s International Association for the Study of Kangker paru (IASLC). Dr Mohamed Ibrahim currently serves as the Vice President (Oncology) for the College of Radiology, Malaysia.

Bidang anu dipikaresepna kalebet paru-paru, payudara, sirah sareng beuheung, urologis sareng tumor peujit gastro. Salian ti kalungguhanana salaku radioterapi stereotactic & spesialis SBRT, Dr Mohamed Ibrahim naratas ngembangkeun perlakuan radioterapi téknologi luhur di Malaysia.

Dr Mohamed Ibrahim parantos nyumbang kana langkung ti 50 jurnal sareng publikasi, sareng janten spiker dina konperénsi onkologi lokal sareng internasional, forum umum sareng média ogé program kaséhatan di Malaysia sareng SEA.

rumah sakit

Rumah Sakit Pantai, Kuala Lumpur, Malaysia

Spésialisasi

  • Sadaya Tumor Padet (Sawawa Ngan)

Prosedur Dilaksanakeun

  • Bedah Radio Stereotactic, SBRT (Radioterapi Awak Stereotactic)
  • IMRT / VMAT

Panilitian & Publikasi

buku
1) Radiotherapy- Pedoman Pasén pikeun terapi Radiasi

jurnal
1) Jeevendra Kanagalingam, Mohamed Ibrahim A.Wahid, Jin-Ching Lin,Nonette A.Cupino, Edward Liu, Jin-Hyoung Kang, Shouki Bazarbashi, Nicole Bender Moreira, Harsha Arumugam, Stefan Mueller, HanlimMoon. Patient and oncologist perception regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion(ADOPT) study in Supportive Care in Cancer, https://doi.org/10.1007/s00520-018-4050-3, Published online : 31 January 2018

2) Weng Heng Tang, Adlinda Alip, Marniza Saad, Vincent Chee EE Phua, Hari Chandran, Yi Hang Tan, Yan Yin Tan, Voon Fong Kua, Mohamed Ibrahim Wahid, Lye Mun Tho. Faktor Prognostik dina Pasén kalayan Karsinoma Paru Sél Non-leutik sareng Metastasis Otak, Perspéktif Malaysia dina jurnal pencegahan kanker Asia Pasifik: APJCP01/2015:16(5) :1901-6

3) Gerald Cc Lim, Emran N Aina, Soon K Cheah, Fuad Ismail, Gwo F Ho, Lye M Tho, Cheng H Yip, Nur A Taib, Kwang J Chong, Jayendran Dharmaratnam, Matin M Abdullah, Ahmad K Mohamed, Kean F Ho, Kananathan Ratnavelu, Kananathan M Lim, Kin W Leong, Ibrahim A Wahid, Teck O Lim. Closing the global cancer divide-performance of breast cancer care services in a middle income developing country. BMC Cancer 03/2014:14(1):212.DOI:10.1186/1471-2407-14-212

4)  A D’cruz, T Lin, A.K.Anand,D Atmakusuma,M J Calaguas, I Chitapanarux, B C Cho, B.C Goh,Y Guo,W S Hsieh, J C Lin, P J Lou, T Lu, K Prabhash, V Sriuranpong, P Tang, V V Vu, I Wahid, K K Ang, A T Chan. Consensus recommendations for management of kanker sirah sareng beuheung in Asian countries: A review of international guidelines in Oral Oncology 07/2013: 49(9).DOI:10.1016/j.oraloncology.2013.05.010

5) Chong-Kin Liam, Mohamed Ibrahim A. Wahid, Pathmanathan Rajadurai, Yoke Queen Cheah, Tiffany Shi Yeen. Epidermal growth factor receptor mutations in lung adénokarsinoma in Malaysian patients in Journal of Thoracic Oncology, Volume 8, Number 6, June 2013

6) GCCLim,NAEmran,GWHo.CHYip,KJChong,MMAbdullah,AKMohamed,YC Foo, KFHo, R.Kananathan, KWLeong, IAWahid,TOLim. AOSOP1 nutup ngabagi kanker: Kinerja jasa perawatan kanker payudara di Malaysia, Nagara Ngembangkeun Panghasilan Tengah di European Journal of Cancer 03/2013,; 49:S1. DOI: 10.1016/S0959-8049(13) 00171-8

7) Norie Kawahara, Haruhiko Sugimura, Akira Nakagawara, Tohru Masui, Jun Miyake, Masanori Akiyama, Ibrahim A Wahid, Xishan Hao, Hideyuki Akaza. Forum Kanker Asia ka-6, naon anu kedah urang laksanakeun pikeun nempatkeun kanker dina agenda kaséhatan global? Ngabagikeun inpormasi nyababkeun kaamanan manusa. Japanese Journal of Onkologi klinis 03/2011, 41 (5): 723-9. DOI: 10.1093

8) Seiji Naito, Yoshihiko Tomita, Sun Young Rha, Hirotsugu Uemura, Mototsugu Oya, He Zhi Song, Li Han Zhong jeung Mohamed Ibrahim Bin A Wahid. Laporan Kelompok Kerja Kanker Ginjal di Japanese Journal of Clinical Oncology (JJCO) Jpn j Clin Oncol 2010:40 (suplemén)i5l-i56

Peryogi bantosan? Tim kami siap ngabantosan anjeun.

Kami ngarepkeun pamulihan gancang tina anu anjeun sayogi sareng anu caket.

×
Mimitian obrolan
Kami Online! Ngobrol Jeung Kami!
Scan kode na
Halo,

Wilujeng sumping di CancerFax!

CancerFax mangrupikeun platform pioneering anu didedikasikeun pikeun ngahubungkeun individu anu nyanghareupan kanker tahap lanjut kalayan terapi sél anu inovatif sapertos terapi CAR T-Cell, terapi TIL, sareng uji klinis di sakuliah dunya.

Hayu urang nyaho naon bisa urang pigawé pikeun anjeun.

1) Pangobatan kanker di luar negeri?
2) Terapi T-Sél mobil
3) Vaksin kanker
4) Konsultasi video online
5) Terapi proton